AJANTPHARM2024-01-012024-03-31 AJANTPHARM2024-01-012024-03-31 AJANTPHARM2024-01-012024-03-31in-bse-fin:OneOperatingExpenses01Member AJANTPHARM2024-01-012024-03-31in-bse-fin:FourOperatingExpenses01Member AJANTPHARM2024-03-31 AJANTPHARM2024-01-012024-03-31in-bse-fin:OneItemsThatWillNotBeReclassifiedToProfitAndLoss01Member AJANTPHARM2024-01-012024-03-31in-bse-fin:FourItemsThatWillNotBeReclassifiedToProfitAndLoss01Member AJANTPHARM2024-01-012024-03-31in-bse-fin:OneItemsThatWillBeReclassifiedToProfitAndLoss01Member AJANTPHARM2024-01-012024-03-31in-bse-fin:FourItemsThatWillBeReclassifiedToProfitAndLoss01Member iso4217:INRxbrli:purexbrli:sharesiso4217:INRxbrli:shares 532331 AJANTPHARM NA Ajanta Pharma Limited Equity 2023-04-01 2024-03-31 2024-05-02 2024-04-22 INR Crores Yearly 14:00:00 16:00:00 2024-05-02 2024-05-02 true Cash Flow Indirect Declaration of unmodified opinion Single segment Pharmaceutical 2024-01-01 2024-03-31 Audited Consolidated 10540800000.00 355000000.00 10895800000.00 2590300000.00 404400000.00 -350900000.00 2335100000.00 15300000.00 342500000.00 2778700000.00 8115400000.00 2780400000.00 0.00 2780400000.00 731100000.00 22100000.00 753200000.00 0.00 2027200000.00 0.00 0.00 0.00 0.00 2027200000.00 -63900000.00 1963300000.00 1963300000.00 0.00 -63900000.00 0.00 252700000.00 2 16.10 16.09 0.00 0.00 16.10 16.09 1. The above consolidated financial results have been reviewed by Audit Committee and approved by the Board of Directors at their meeting held on 2 May 2024. The statutory auditors have expressed an unmodified opinion on the results for the quarter and year ended 31 March 2024. The audit report has been filed with the stock exchange and is available on the company's website. 2. The figures for the quarter ended 31 March 2024 and 31 March 2023 are the balancing figures between audited figures in respect of full financial year and the unaudited published year to date figures upto the third quarter ended 31 December 2023 and 31 December 2022 respectively. 3. The consolidated audited financial results of the Company, its wholly owned subsidiaries and step-down subsidiary (“the Group”) have been prepared as per Ind AS 110 on Consolidated Financial Statements . There is no minority interest. 4. Board of Directors have approved buy back of its 10,28,881 (previous year 22,10,500) equity shares, being 0.82% (previous year 2.59%) of the total paid up equity share capital at Rs. 2,770 (previous year Rs. 1,425) per equity share for an aggregate amount of Rs. 285.00 crores (previous year Rs. 315.00 crores). Previous year the buy back opened on 31 March 2023, closed on 10 April 2023 and Company extinguished those shares on 19 April 2023. 5. Other income / Other expense includes : Quarter ended Year ended Rs. in Crore 31-Mar-24 31-Dec-23 31-Mar-23 31-Mar-24 31-Mar-23 Foreign exchange gain (in other income) 19.66 4.11 24.52 38.69 66.07 Foreign exchange loss (in other expense) - 7.58 21.71 - 18.82 6. During the year 1,000 (previous year 1,000) equity shares of Rs. 2 each, fully paid up, were allotted upon exercise of vested options pursuant to the Share Based Incentive Plan, 2019, resulting in an increase in the paid-up share capital by Rs. 2,000 (previous year Rs. 2,000) and securities premium by Rs. 0.18 crores (previous year Rs. 0.18 crores). Single segment 2023-04-01 2024-03-31 Audited Consolidated 42087100000.00 846000000.00 42933100000.00 9394300000.00 1663500000.00 -392100000.00 9003400000.00 72100000.00 1354000000.00 10698600000.00 31793800000.00 11139300000.00 0.00 11139300000.00 3220600000.00 -243000000.00 2977600000.00 0.00 8161700000.00 0.00 0.00 0.00 0.00 8161700000.00 8100000.00 8169800000.00 8169800000.00 0.00 8100000.00 0.00 252700000.00 2 35420900000.00 64.82 64.77 0.00 0.00 64.82 64.77 Other Expenses 2778700000.00 Other Expenses 10698600000.00 0.00 13841300000.00 2564500000.00 0.00 0.00 950600000.00 0.00 0.00 0.00 185800000.00 0.00 0.00 93600000.00 279400000.00 1344500000.00 94400000.00 19074700000.00 8283600000.00 3300500000.00 12468400000.00 1294900000.00 12800000.00 339600000.00 190200000.00 17606400000.00 0.00 1330700000.00 27220700000.00 88500000.00 0.00 46383900000.00 252700000.00 35420900000.00 35673600000.00 35673600000.00 0.00 0.00 248900000.00 248900000.00 395400000.00 1085000000.00 0.00 23400000.00 1752700000.00 14900000.00 4632000000.00 3083000000.00 7729900000.00 597300000.00 177600000.00 447700000.00 0.00 8952500000.00 5100000.00 0.00 10710300000.00 46383900000.00 1. The above consolidated financial results have been reviewed by Audit Committee and approved by the Board of Directors at their meeting held on 2 May 2024. The statutory auditors have expressed an unmodified opinion on the results for the quarter and year ended 31 March 2024. The audit report has been filed with the stock exchange and is available on the company's website. 2. The figures for the quarter ended 31 March 2024 and 31 March 2023 are the balancing figures between audited figures in respect of full financial year and the unaudited published year to date figures upto the third quarter ended 31 December 2023 and 31 December 2022 respectively. 3. The consolidated audited financial results of the Company, its wholly owned subsidiaries and step-down subsidiary (“the Group”) have been prepared as per Ind AS 110 on Consolidated Financial Statements . There is no minority interest. 4. Board of Directors have approved buy back of its 10,28,881 (previous year 22,10,500) equity shares, being 0.82% (previous year 2.59%) of the total paid up equity share capital at Rs. 2,770 (previous year Rs. 1,425) per equity share for an aggregate amount of Rs. 285.00 crores (previous year Rs. 315.00 crores). Previous year the buy back opened on 31 March 2023, closed on 10 April 2023 and Company extinguished those shares on 19 April 2023. 5. Other income / Other expense includes : Quarter ended Year ended Rs. in Crore 31-Mar-24 31-Dec-23 31-Mar-23 31-Mar-24 31-Mar-23 Foreign exchange gain (in other income) 19.66 4.11 24.52 38.69 66.07 Foreign exchange loss (in other expense) - 7.58 21.71 - 18.82 6. During the year 1,000 (previous year 1,000) equity shares of Rs. 2 each, fully paid up, were allotted upon exercise of vested options pursuant to the Share Based Incentive Plan, 2019, resulting in an increase in the paid-up share capital by Rs. 2,000 (previous year Rs. 2,000) and securities premium by Rs. 0.18 crores (previous year Rs. 0.18 crores). 72100000.00 -123000000.00 -1788800000.00 0.00 -409400000.00 -10100000.00 17300000.00 174000000.00 0.00 408500000.00 0.00 365640000.00 0.00 1354000000.00 -34900000.00 12200000.00 153900000.00 195240000.00 6900000.00 -94200000.00 0.00 381200000.00 54900000.00 -137100000.00 0.00 0.00 0.00 -3300000.00 0.00 -167320000.00 10971980000.00 0.00 0.00 0.00 3121300000.00 0.00 7850680000.00 0.00 0.00 22573900000.00 20797600000.00 0.00 0.00 0.00 0.00 133800000.00 1524100000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 270000000.00 0.00 -2100000.00 0.00 653900000.00 0.00 0.00 0.00 0.00 3891900000.00 0.00 0.00 0.00 600000.00 0.00 0.00 162300000.00 6421700000.00 35300000.00 0.00 0.00 -10510600000.00 -2006020000.00 2600000.00 -2003420000.00 3298300000.00 1294880000.00 Amount of items that will not be reclassified to profit and loss -14400000.00 Amount of items that will not be reclassified to profit and loss -38800000.00 -14400000.00 -38800000.00 -5100000.00 -13600000.00 Amount of items that will be reclassified to profit and loss -54600000.00 Amount of items that will be reclassified to profit and loss 33300000.00 -54600000.00 33300000.00 0.00 0.00